Postmarketing safety evaluation of belimumab: a pharmacovigilance analysis
Objective The present study aimed to provide a comprehensive evaluation of the postmarketing safety of belimumab based on the Food and Drug Administration Adverse Event Reporting System (FAERS) database.Methods Adverse event (AE) reports in the FAERS database from January 2021 to December 2023 were...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMJ Publishing Group
2025-01-01
|
| Series: | Lupus Science and Medicine |
| Acceso en liña: | https://lupus.bmj.com/content/12/1/e001400.full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|